State Codes and Statutes

Statutes > Illinois > Chapter720 > 1941 > 072005700HArt_I


      (720 ILCS 570/Art. I heading)
ARTICLE I

    (720 ILCS 570/100) (from Ch. 56 1/2, par. 1100)
    Sec. 100. Legislative intent. It is the intent of the General Assembly, recognizing the rising incidence in the abuse of drugs and other dangerous substances and its resultant damage to the peace, health, and welfare of the citizens of Illinois, to provide a system of control over the distribution and use of controlled substances which will more effectively: (1) limit access of such substances only to those persons who have demonstrated an appropriate sense of responsibility and have a lawful and legitimate reason to possess them; (2) deter the unlawful and destructive abuse of controlled substances; (3) penalize most heavily the illicit traffickers or profiteers of controlled substances, who propagate and perpetuate the abuse of such substances with reckless disregard for its consumptive consequences upon every element of society; (4) acknowledge the functional and consequential differences between the various types of controlled substances and provide for correspondingly different degrees of control over each of the various types; (5) unify where feasible and codify the efforts of this State to conform with the regulatory systems of the Federal government and other states to establish national coordination of efforts to control the abuse of controlled substances; and (6) provide law enforcement authorities with the necessary resources to make this system efficacious.
    It is not the intent of the General Assembly to treat the unlawful user or occasional petty distributor of controlled substances with the same severity as the large‑scale, unlawful purveyors and traffickers of controlled substances. However, it is recognized that persons who violate this Act with respect to the manufacture, delivery, possession with intent to deliver, or possession of more than one type of controlled substance listed herein may accordingly receive multiple convictions and sentences under each Section of this Act. To this end, guidelines have been provided, along with a wide latitude in sentencing discretion, to enable the sentencing court to order penalties in each case which are appropriate for the purposes of this Act.
(Source: P.A. 89‑404, eff. 8‑20‑95; 90‑593, eff. 6‑19‑98.)

    (720 ILCS 570/101) (from Ch. 56 1/2, par. 1101)
    Sec. 101.
    This Act shall be known as and may be cited as the "Illinois Controlled Substances Act."
(Source: P. A. 77‑757.)

    (720 ILCS 570/102)(from Ch. 56 1/2, par. 1102)
    Sec. 102. Definitions. As used in this Act, unless the context otherwise requires:
    (a) "Addict" means any person who habitually uses any drug, chemical, substance or dangerous drug other than alcohol so as to endanger the public morals, health, safety or welfare or who is so far addicted to the use of a dangerous drug or controlled substance other than alcohol as to have lost the power of self control with reference to his addiction.
    (b) "Administer" means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a patient, research subject, or animal (as defined by the Humane Euthanasia in Animal Shelters Act) by:
        (1) a practitioner (or, in his presence, by his
     authorized agent),
        (2) the patient or research subject at the lawful
     direction of the practitioner, or
        (3) a euthanasia technician as defined by the Humane
     Euthanasia in Animal Shelters Act.
    (c) "Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. It does not include a common or contract carrier, public warehouseman or employee of the carrier or warehouseman.
    (c‑1) "Anabolic Steroids" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:
            (i) boldenone,
            (ii) chlorotestosterone,
            (iii) chostebol,
            (iv) dehydrochlormethyltestosterone,
            (v) dihydrotestosterone,
            (vi) drostanolone,
            (vii) ethylestrenol,
            (viii) fluoxymesterone,
            (ix) formebulone,
            (x) mesterolone,
            (xi) methandienone,
            (xii) methandranone,
            (xiii) methandriol,
            (xiv) methandrostenolone,
            (xv) methenolone,
            (xvi) methyltestosterone,
            (xvii) mibolerone,
            (xviii) nandrolone,
            (xix) norethandrolone,
            (xx) oxandrolone,
            (xxi) oxymesterone,
            (xxii) oxymetholone,
            (xxiii) stanolone,
            (xxiv) stanozolol,
            (xxv) testolactone,
            (xxvi) testosterone,
            (xxvii) trenbolone, and
            (xxviii) any salt, ester, or isomer of a drug or
         substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.
    Any person who is otherwise lawfully in possession of an anabolic steroid, or who otherwise lawfully manufactures, distributes, dispenses, delivers, or possesses with intent to deliver an anabolic steroid, which anabolic steroid is expressly intended for and lawfully allowed to be administered through implants to livestock or other nonhuman species, and which is approved by the Secretary of Health and Human Services for such administration, and which the person intends to administer or have administered through such implants, shall not be considered to be in unauthorized possession or to unlawfully manufacture, distribute, dispense, deliver, or possess with intent to deliver such anabolic steroid for purposes of this Act.
    (d) "Administration" means the Drug Enforcement Administration, United States Department of Justice, or its successor agency.
    (e) "Control" means to add a drug or other substance, or immediate precursor, to a Schedule under Article II of this Act whether by transfer from another Schedule or otherwise.
    (f) "Controlled Substance" means a drug, substance, or immediate precursor in the Schedules of Article II of this Act.
    (g) "Counterfeit substance" means a controlled substance, which, or the container or labeling of which, without authorization bears the trademark, trade name, or other identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person who in fact manufactured, distributed, or dispensed the substance.
    (h) "Deliver" or "delivery" means the actual, constructive or attempted transfer of possession of a controlled substance, with or without consideration, whether or not there is an agency relationship.
    (i) "Department" means the Illinois Department of Human Services (as successor to the Department of Alcoholism and Substance Abuse) or its successor agency.
    (j) "Department of State Police" means the Department of State Police of the State of Illinois or its successor agency.
    (k) "Department of Corrections" means the Department of Corrections of the State of Illinois or its successor agency.
    (l) "Department of Professional Regulation" means the Department of Professional Regulation of the State of Illinois or its successor agency.
    (m) "Depressant" or "stimulant substance" means:
        (1) a drug which contains any quantity of (i)
     barbituric acid or any of the salts of barbituric acid which has been designated as habit forming under section 502 (d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352 (d)); or
        (2) a drug which contains any quantity of (i)
     amphetamine or methamphetamine and any of their optical isomers; (ii) any salt of amphetamine or methamphetamine or any salt of an optical isomer of amphetamine; or (iii) any substance which the Department, after investigation, has found to be, and by rule designated as, habit forming because of its depressant or stimulant effect on the central nervous system; or
        (3) lysergic acid diethylamide; or
        (4) any drug which contains any quantity of a
     substance which the Department, after investigation, has found to have, and by rule designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect.
    (n) (Blank).
    (o) "Director" means the Director of the Department of State Police or the Department of Professional Regulation or his designated agents.
    (p) "Dispense" means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a prescriber, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.
    (q) "Dispenser" means a practitioner who dispenses.
    (r) "Distribute" means to deliver, other than by administering or dispensing, a controlled substance.
    (s) "Distributor" means a person who distributes.
    (t) "Drug" means (1) substances recognized as drugs in the official United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; (2) substances intended for use in diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals; (3) substances (other than food) intended to affect the structure of any function of the body of man or animals and (4) substances intended for use as a component of any article specified in clause (1), (2), or (3) of this subsection. It does not include devices or their components, parts, or accessories.
    (t‑5) "Euthanasia agency" means an entity certified by the Department of Professional Regulation for the purpose of animal euthanasia that holds an animal control facility license or animal shelter license under the Animal Welfare Act. A euthanasia agency is authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.
    (t‑10) "Euthanasia drugs" means Schedule II or Schedule III substances (nonnarcotic controlled substances) that are used by a euthanasia agency for the purpose of animal euthanasia.
    (u) "Good faith" means the prescribing or dispensing of a controlled substance by a practitioner in the regular course of professional treatment to or for any person who is under his treatment for a pathology or condition other than that individual's physical or psychological dependence upon or addiction to a controlled substance, except as provided herein: and application of the term to a pharmacist shall mean the dispensing of a controlled substance pursuant to the prescriber's order which in the professional judgment of the pharmacist is lawful. The pharmacist shall be guided by accepted professional standards including, but not limited to the following, in making the judgment:
        (1) lack of consistency of doctor‑patient
     relationship,
        (2) frequency of prescriptions for same drug by one
     prescriber for large numbers of patients,
        (3) quantities beyond those normally prescribed,
        (4) unusual dosages,
        (5) unusual geographic distances between patient,
     pharmacist and prescriber,
        (6) consistent prescribing of habit‑forming drugs.
    (u‑1) "Home infusion services" means services provided by a pharmacy in compounding solutions for direct administration to a patient in a private residence, long‑term care facility, or hospice setting by means of parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion.
    (v) "Immediate precursor" means a substance:
        (1) which the Department has found to be and by rule
     designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;
        (2) which is an immediate chemical intermediary used
     or likely to be used in the manufacture of such controlled substance; and
        (3) the control of which is necessary to prevent,
     curtail or limit the manufacture of such controlled substance.
    (w) "Instructional activities" means the acts of teaching, educating or instructing by practitioners using controlled substances within educational facilities approved by the State Board of Education or its successor agency.
    (x) "Local authorities" means a duly organized State, County or Municipal peace unit or police force.
    (y) "Look‑alike substance" means a substance, other than a controlled substance which (1) by overall dosage unit appearance, including shape, color, size, markings or lack thereof, taste, consistency, or any other identifying physical characteristic of the substance, would lead a reasonable person to believe that the substance is a controlled substance, or (2) is expressly or impliedly represented to be a controlled substance or is distributed under circumstances which would lead a reasonable person to believe that the substance is a controlled substance. For the purpose of determining whether the representations made or the circumstances of the distribution would lead a reasonable person to believe the substance to be a controlled substance under this clause (2) of subsection (y), the court or other authority may consider the following factors in addition to any other factor that may be relevant:
        (a) statements made by the owner or person in control
     of the substance concerning its nature, use or effect;
        (b) statements made to the buyer or recipient that
     the substance may be resold for profit;
        (c) whether the substance is packaged in a manner
     normally used for the illegal distribution of controlled substances;
        (d) whether the distribution or attempted
     distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.
    Clause (1) of this subsection (y) shall not apply to a noncontrolled substance in its finished dosage form that was initially introduced into commerce prior to the initial introduction into commerce of a controlled substance in its finished dosage form which it may substantially resemble.
    Nothing in this subsection (y) prohibits the dispensing or distributing of noncontrolled substances by persons authorized to dispense and distribute controlled substances under this Act, provided that such action would be deemed to be carried out in good faith under subsection (u) if the substances involved were controlled substances.
    Nothing in this subsection (y) or in this Act prohibits the manufacture, preparation, propagation, compounding, processing, packaging, advertising or distribution of a drug or drugs by any person registered pursuant to Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
    (y‑1) "Mail‑order pharmacy" means a pharmacy that is located in a state of the United States, other than Illinois, that delivers, dispenses or distributes, through the United States Postal Service or other common carrier, to Illinois residents, any substance which requires a prescription.
    (z) "Manufacture" means the production, preparation, propagation, compounding, conversion or processing of a controlled substance other than methamphetamine, either directly or indirectly, by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling of its container, except that this term does not include:
        (1) by an ultimate user, the preparation or
     compounding of a controlled substance for his own use; or
        (2) by a practitioner, or his authorized agent under
     his supervision, the preparation, compounding, packaging, or labeling of a controlled substance:
            (a) as an incident to his administering or
         dispensing of a controlled substance in the course of his professional practice; or
            (b) as an incident to lawful research, teaching
         or chemical analysis and not for sale.
    (z‑1) (Blank).
    (aa) "Narcotic drug" means any of the following, whether produced directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
        (1) opium and opiate, and any salt, compound,
     derivative, or preparation of opium or opiate;
        (2) any salt, compound, isomer, derivative, or
     preparation thereof which is chemically equivalent or identical with any of the substances referred to in clause (1), but not including the isoquinoline alkaloids of opium;
        (3) opium poppy and poppy straw;
        (4) coca leaves and any salts, compound, isomer, salt
     of an isomer, derivative, or preparation of coca leaves including cocaine or ecgonine, and any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine (for the purpose of this paragraph, the term "isomer" includes optical, positional and geometric isomers).
    (bb) "Nurse" means a registered nurse licensed under the Nurse Practice Act.
    (cc) (Blank).
    (dd) "Opiate" means any substance having an addiction forming or addiction sustaining liability similar to morphine or being capable of conversion into a drug having addiction forming or addiction sustaining liability.
    (ee) "Opium poppy" means the plant of the species Papaver somniferum L., except its seeds.
    (ff) "Parole and Pardon Board" means the Parole and Pardon Board of the State of Illinois or its successor agency.
    (gg) "Person" means any individual, corporation, mail‑order pharmacy, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other entity.
    (hh) "Pharmacist" means any person who holds a license or certificate of registration as a registered pharmacist, a local registered pharmacist or a registered assistant pharmacist under the Pharmacy Practice Act.
    (ii) "Pharmacy" means any store, ship or other place in which pharmacy is authorized to be practiced under the Pharmacy Practice Act.
    (jj) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.
    (kk) "Practitioner" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist, veterinarian, scientific investigator, pharmacist, physician assistant, advanced practice nurse, licensed practical nurse, registered nurse, hospital, laboratory, or pharmacy, or other person licensed, registered, or otherwise lawfully permitted by the United States or this State to distribute, dispense, conduct research with respect to, administer or use in teaching or chemical analysis, a controlled substance in the course of professional practice or research.
    (ll) "Pre‑printed prescription" means a written prescription upon which the designated drug has been indicated prior to the time of issuance.
    (mm) "Prescriber" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist or veterinarian who issues a prescription, a physician assistant who issues a prescription for a controlled substance in accordance with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5 of the Physician Assistant Practice Act of 1987, or an advanced practice nurse with prescriptive authority delegated under Section 65‑40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation, and a written collaborative agreement under Section 65‑35 of the Nurse Practice Act.
    (nn) "Prescription" means a lawful written, facsimile, or verbal order of a physician licensed to practice medicine in all its branches, dentist, podiatrist or veterinarian for any controlled substance, of an optometrist for a Schedule III, IV, or V controlled substance in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a physician assistant for a controlled substance in accordance with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5 of the Physician Assistant Practice Act of 1987, or of an advanced practice nurse with prescriptive authority delegated under Section 65‑40 of the Nurse Practice Act who issues a prescription for a controlled substance in accordance with Section 303.05, a written delegation, and a written collaborative agreement under Section 65‑35 of the Nurse Practice Act.
    (oo) "Production" or "produce" means manufacture, planting, cultivating, growing, or harvesting of a controlled substance other than methamphetamine.
    (pp) "Registrant" means every person who is required to register under Section 302 of this Act.
    (qq) "Registry number" means the number assigned to each person authorized to handle controlled substances under the laws of the United States and of this State.
    (rr) "State" includes the State of Illinois and any state, district, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States of America.
    (ss) "Ultimate user" means a person who lawfully possesses a controlled substance for his own use or for the use of a member of his household or for administering to an animal owned by him or by a member of his household.
(Source: P.A. 95‑242, eff. 1‑1‑08; 95‑639, eff. 10‑5‑07; 95‑689, eff. 10‑29‑07; 95‑876, eff. 8‑21‑08; 96‑189, eff. 8‑10‑09; 96‑268, eff. 8‑11‑09.)

    (720 ILCS 570/103)(from Ch. 56 1/2, par. 1103)
    Sec. 103. Scope of Act. Nothing in this Act limits the lawful authority granted by the Medical Practice Act of 1987, the Nurse Practice Act, the Illinois Optometric Practice Act of 1987, or the Pharmacy Practice Act.
(Source: P.A. 95‑242, eff. 1‑1‑08; 95‑639, eff. 10‑5‑07; 95‑689, eff. 10‑29‑07; 95‑876, eff. 8‑21‑08.)

State Codes and Statutes

Statutes > Illinois > Chapter720 > 1941 > 072005700HArt_I


      (720 ILCS 570/Art. I heading)
ARTICLE I

    (720 ILCS 570/100) (from Ch. 56 1/2, par. 1100)
    Sec. 100. Legislative intent. It is the intent of the General Assembly, recognizing the rising incidence in the abuse of drugs and other dangerous substances and its resultant damage to the peace, health, and welfare of the citizens of Illinois, to provide a system of control over the distribution and use of controlled substances which will more effectively: (1) limit access of such substances only to those persons who have demonstrated an appropriate sense of responsibility and have a lawful and legitimate reason to possess them; (2) deter the unlawful and destructive abuse of controlled substances; (3) penalize most heavily the illicit traffickers or profiteers of controlled substances, who propagate and perpetuate the abuse of such substances with reckless disregard for its consumptive consequences upon every element of society; (4) acknowledge the functional and consequential differences between the various types of controlled substances and provide for correspondingly different degrees of control over each of the various types; (5) unify where feasible and codify the efforts of this State to conform with the regulatory systems of the Federal government and other states to establish national coordination of efforts to control the abuse of controlled substances; and (6) provide law enforcement authorities with the necessary resources to make this system efficacious.
    It is not the intent of the General Assembly to treat the unlawful user or occasional petty distributor of controlled substances with the same severity as the large‑scale, unlawful purveyors and traffickers of controlled substances. However, it is recognized that persons who violate this Act with respect to the manufacture, delivery, possession with intent to deliver, or possession of more than one type of controlled substance listed herein may accordingly receive multiple convictions and sentences under each Section of this Act. To this end, guidelines have been provided, along with a wide latitude in sentencing discretion, to enable the sentencing court to order penalties in each case which are appropriate for the purposes of this Act.
(Source: P.A. 89‑404, eff. 8‑20‑95; 90‑593, eff. 6‑19‑98.)

    (720 ILCS 570/101) (from Ch. 56 1/2, par. 1101)
    Sec. 101.
    This Act shall be known as and may be cited as the "Illinois Controlled Substances Act."
(Source: P. A. 77‑757.)

    (720 ILCS 570/102)(from Ch. 56 1/2, par. 1102)
    Sec. 102. Definitions. As used in this Act, unless the context otherwise requires:
    (a) "Addict" means any person who habitually uses any drug, chemical, substance or dangerous drug other than alcohol so as to endanger the public morals, health, safety or welfare or who is so far addicted to the use of a dangerous drug or controlled substance other than alcohol as to have lost the power of self control with reference to his addiction.
    (b) "Administer" means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a patient, research subject, or animal (as defined by the Humane Euthanasia in Animal Shelters Act) by:
        (1) a practitioner (or, in his presence, by his
     authorized agent),
        (2) the patient or research subject at the lawful
     direction of the practitioner, or
        (3) a euthanasia technician as defined by the Humane
     Euthanasia in Animal Shelters Act.
    (c) "Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. It does not include a common or contract carrier, public warehouseman or employee of the carrier or warehouseman.
    (c‑1) "Anabolic Steroids" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:
            (i) boldenone,
            (ii) chlorotestosterone,
            (iii) chostebol,
            (iv) dehydrochlormethyltestosterone,
            (v) dihydrotestosterone,
            (vi) drostanolone,
            (vii) ethylestrenol,
            (viii) fluoxymesterone,
            (ix) formebulone,
            (x) mesterolone,
            (xi) methandienone,
            (xii) methandranone,
            (xiii) methandriol,
            (xiv) methandrostenolone,
            (xv) methenolone,
            (xvi) methyltestosterone,
            (xvii) mibolerone,
            (xviii) nandrolone,
            (xix) norethandrolone,
            (xx) oxandrolone,
            (xxi) oxymesterone,
            (xxii) oxymetholone,
            (xxiii) stanolone,
            (xxiv) stanozolol,
            (xxv) testolactone,
            (xxvi) testosterone,
            (xxvii) trenbolone, and
            (xxviii) any salt, ester, or isomer of a drug or
         substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.
    Any person who is otherwise lawfully in possession of an anabolic steroid, or who otherwise lawfully manufactures, distributes, dispenses, delivers, or possesses with intent to deliver an anabolic steroid, which anabolic steroid is expressly intended for and lawfully allowed to be administered through implants to livestock or other nonhuman species, and which is approved by the Secretary of Health and Human Services for such administration, and which the person intends to administer or have administered through such implants, shall not be considered to be in unauthorized possession or to unlawfully manufacture, distribute, dispense, deliver, or possess with intent to deliver such anabolic steroid for purposes of this Act.
    (d) "Administration" means the Drug Enforcement Administration, United States Department of Justice, or its successor agency.
    (e) "Control" means to add a drug or other substance, or immediate precursor, to a Schedule under Article II of this Act whether by transfer from another Schedule or otherwise.
    (f) "Controlled Substance" means a drug, substance, or immediate precursor in the Schedules of Article II of this Act.
    (g) "Counterfeit substance" means a controlled substance, which, or the container or labeling of which, without authorization bears the trademark, trade name, or other identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person who in fact manufactured, distributed, or dispensed the substance.
    (h) "Deliver" or "delivery" means the actual, constructive or attempted transfer of possession of a controlled substance, with or without consideration, whether or not there is an agency relationship.
    (i) "Department" means the Illinois Department of Human Services (as successor to the Department of Alcoholism and Substance Abuse) or its successor agency.
    (j) "Department of State Police" means the Department of State Police of the State of Illinois or its successor agency.
    (k) "Department of Corrections" means the Department of Corrections of the State of Illinois or its successor agency.
    (l) "Department of Professional Regulation" means the Department of Professional Regulation of the State of Illinois or its successor agency.
    (m) "Depressant" or "stimulant substance" means:
        (1) a drug which contains any quantity of (i)
     barbituric acid or any of the salts of barbituric acid which has been designated as habit forming under section 502 (d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352 (d)); or
        (2) a drug which contains any quantity of (i)
     amphetamine or methamphetamine and any of their optical isomers; (ii) any salt of amphetamine or methamphetamine or any salt of an optical isomer of amphetamine; or (iii) any substance which the Department, after investigation, has found to be, and by rule designated as, habit forming because of its depressant or stimulant effect on the central nervous system; or
        (3) lysergic acid diethylamide; or
        (4) any drug which contains any quantity of a
     substance which the Department, after investigation, has found to have, and by rule designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect.
    (n) (Blank).
    (o) "Director" means the Director of the Department of State Police or the Department of Professional Regulation or his designated agents.
    (p) "Dispense" means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a prescriber, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.
    (q) "Dispenser" means a practitioner who dispenses.
    (r) "Distribute" means to deliver, other than by administering or dispensing, a controlled substance.
    (s) "Distributor" means a person who distributes.
    (t) "Drug" means (1) substances recognized as drugs in the official United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; (2) substances intended for use in diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals; (3) substances (other than food) intended to affect the structure of any function of the body of man or animals and (4) substances intended for use as a component of any article specified in clause (1), (2), or (3) of this subsection. It does not include devices or their components, parts, or accessories.
    (t‑5) "Euthanasia agency" means an entity certified by the Department of Professional Regulation for the purpose of animal euthanasia that holds an animal control facility license or animal shelter license under the Animal Welfare Act. A euthanasia agency is authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.
    (t‑10) "Euthanasia drugs" means Schedule II or Schedule III substances (nonnarcotic controlled substances) that are used by a euthanasia agency for the purpose of animal euthanasia.
    (u) "Good faith" means the prescribing or dispensing of a controlled substance by a practitioner in the regular course of professional treatment to or for any person who is under his treatment for a pathology or condition other than that individual's physical or psychological dependence upon or addiction to a controlled substance, except as provided herein: and application of the term to a pharmacist shall mean the dispensing of a controlled substance pursuant to the prescriber's order which in the professional judgment of the pharmacist is lawful. The pharmacist shall be guided by accepted professional standards including, but not limited to the following, in making the judgment:
        (1) lack of consistency of doctor‑patient
     relationship,
        (2) frequency of prescriptions for same drug by one
     prescriber for large numbers of patients,
        (3) quantities beyond those normally prescribed,
        (4) unusual dosages,
        (5) unusual geographic distances between patient,
     pharmacist and prescriber,
        (6) consistent prescribing of habit‑forming drugs.
    (u‑1) "Home infusion services" means services provided by a pharmacy in compounding solutions for direct administration to a patient in a private residence, long‑term care facility, or hospice setting by means of parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion.
    (v) "Immediate precursor" means a substance:
        (1) which the Department has found to be and by rule
     designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;
        (2) which is an immediate chemical intermediary used
     or likely to be used in the manufacture of such controlled substance; and
        (3) the control of which is necessary to prevent,
     curtail or limit the manufacture of such controlled substance.
    (w) "Instructional activities" means the acts of teaching, educating or instructing by practitioners using controlled substances within educational facilities approved by the State Board of Education or its successor agency.
    (x) "Local authorities" means a duly organized State, County or Municipal peace unit or police force.
    (y) "Look‑alike substance" means a substance, other than a controlled substance which (1) by overall dosage unit appearance, including shape, color, size, markings or lack thereof, taste, consistency, or any other identifying physical characteristic of the substance, would lead a reasonable person to believe that the substance is a controlled substance, or (2) is expressly or impliedly represented to be a controlled substance or is distributed under circumstances which would lead a reasonable person to believe that the substance is a controlled substance. For the purpose of determining whether the representations made or the circumstances of the distribution would lead a reasonable person to believe the substance to be a controlled substance under this clause (2) of subsection (y), the court or other authority may consider the following factors in addition to any other factor that may be relevant:
        (a) statements made by the owner or person in control
     of the substance concerning its nature, use or effect;
        (b) statements made to the buyer or recipient that
     the substance may be resold for profit;
        (c) whether the substance is packaged in a manner
     normally used for the illegal distribution of controlled substances;
        (d) whether the distribution or attempted
     distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.
    Clause (1) of this subsection (y) shall not apply to a noncontrolled substance in its finished dosage form that was initially introduced into commerce prior to the initial introduction into commerce of a controlled substance in its finished dosage form which it may substantially resemble.
    Nothing in this subsection (y) prohibits the dispensing or distributing of noncontrolled substances by persons authorized to dispense and distribute controlled substances under this Act, provided that such action would be deemed to be carried out in good faith under subsection (u) if the substances involved were controlled substances.
    Nothing in this subsection (y) or in this Act prohibits the manufacture, preparation, propagation, compounding, processing, packaging, advertising or distribution of a drug or drugs by any person registered pursuant to Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
    (y‑1) "Mail‑order pharmacy" means a pharmacy that is located in a state of the United States, other than Illinois, that delivers, dispenses or distributes, through the United States Postal Service or other common carrier, to Illinois residents, any substance which requires a prescription.
    (z) "Manufacture" means the production, preparation, propagation, compounding, conversion or processing of a controlled substance other than methamphetamine, either directly or indirectly, by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling of its container, except that this term does not include:
        (1) by an ultimate user, the preparation or
     compounding of a controlled substance for his own use; or
        (2) by a practitioner, or his authorized agent under
     his supervision, the preparation, compounding, packaging, or labeling of a controlled substance:
            (a) as an incident to his administering or
         dispensing of a controlled substance in the course of his professional practice; or
            (b) as an incident to lawful research, teaching
         or chemical analysis and not for sale.
    (z‑1) (Blank).
    (aa) "Narcotic drug" means any of the following, whether produced directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
        (1) opium and opiate, and any salt, compound,
     derivative, or preparation of opium or opiate;
        (2) any salt, compound, isomer, derivative, or
     preparation thereof which is chemically equivalent or identical with any of the substances referred to in clause (1), but not including the isoquinoline alkaloids of opium;
        (3) opium poppy and poppy straw;
        (4) coca leaves and any salts, compound, isomer, salt
     of an isomer, derivative, or preparation of coca leaves including cocaine or ecgonine, and any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine (for the purpose of this paragraph, the term "isomer" includes optical, positional and geometric isomers).
    (bb) "Nurse" means a registered nurse licensed under the Nurse Practice Act.
    (cc) (Blank).
    (dd) "Opiate" means any substance having an addiction forming or addiction sustaining liability similar to morphine or being capable of conversion into a drug having addiction forming or addiction sustaining liability.
    (ee) "Opium poppy" means the plant of the species Papaver somniferum L., except its seeds.
    (ff) "Parole and Pardon Board" means the Parole and Pardon Board of the State of Illinois or its successor agency.
    (gg) "Person" means any individual, corporation, mail‑order pharmacy, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other entity.
    (hh) "Pharmacist" means any person who holds a license or certificate of registration as a registered pharmacist, a local registered pharmacist or a registered assistant pharmacist under the Pharmacy Practice Act.
    (ii) "Pharmacy" means any store, ship or other place in which pharmacy is authorized to be practiced under the Pharmacy Practice Act.
    (jj) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.
    (kk) "Practitioner" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist, veterinarian, scientific investigator, pharmacist, physician assistant, advanced practice nurse, licensed practical nurse, registered nurse, hospital, laboratory, or pharmacy, or other person licensed, registered, or otherwise lawfully permitted by the United States or this State to distribute, dispense, conduct research with respect to, administer or use in teaching or chemical analysis, a controlled substance in the course of professional practice or research.
    (ll) "Pre‑printed prescription" means a written prescription upon which the designated drug has been indicated prior to the time of issuance.
    (mm) "Prescriber" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist or veterinarian who issues a prescription, a physician assistant who issues a prescription for a controlled substance in accordance with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5 of the Physician Assistant Practice Act of 1987, or an advanced practice nurse with prescriptive authority delegated under Section 65‑40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation, and a written collaborative agreement under Section 65‑35 of the Nurse Practice Act.
    (nn) "Prescription" means a lawful written, facsimile, or verbal order of a physician licensed to practice medicine in all its branches, dentist, podiatrist or veterinarian for any controlled substance, of an optometrist for a Schedule III, IV, or V controlled substance in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a physician assistant for a controlled substance in accordance with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5 of the Physician Assistant Practice Act of 1987, or of an advanced practice nurse with prescriptive authority delegated under Section 65‑40 of the Nurse Practice Act who issues a prescription for a controlled substance in accordance with Section 303.05, a written delegation, and a written collaborative agreement under Section 65‑35 of the Nurse Practice Act.
    (oo) "Production" or "produce" means manufacture, planting, cultivating, growing, or harvesting of a controlled substance other than methamphetamine.
    (pp) "Registrant" means every person who is required to register under Section 302 of this Act.
    (qq) "Registry number" means the number assigned to each person authorized to handle controlled substances under the laws of the United States and of this State.
    (rr) "State" includes the State of Illinois and any state, district, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States of America.
    (ss) "Ultimate user" means a person who lawfully possesses a controlled substance for his own use or for the use of a member of his household or for administering to an animal owned by him or by a member of his household.
(Source: P.A. 95‑242, eff. 1‑1‑08; 95‑639, eff. 10‑5‑07; 95‑689, eff. 10‑29‑07; 95‑876, eff. 8‑21‑08; 96‑189, eff. 8‑10‑09; 96‑268, eff. 8‑11‑09.)

    (720 ILCS 570/103)(from Ch. 56 1/2, par. 1103)
    Sec. 103. Scope of Act. Nothing in this Act limits the lawful authority granted by the Medical Practice Act of 1987, the Nurse Practice Act, the Illinois Optometric Practice Act of 1987, or the Pharmacy Practice Act.
(Source: P.A. 95‑242, eff. 1‑1‑08; 95‑639, eff. 10‑5‑07; 95‑689, eff. 10‑29‑07; 95‑876, eff. 8‑21‑08.)

State Codes and Statutes

State Codes and Statutes

Statutes > Illinois > Chapter720 > 1941 > 072005700HArt_I


      (720 ILCS 570/Art. I heading)
ARTICLE I

    (720 ILCS 570/100) (from Ch. 56 1/2, par. 1100)
    Sec. 100. Legislative intent. It is the intent of the General Assembly, recognizing the rising incidence in the abuse of drugs and other dangerous substances and its resultant damage to the peace, health, and welfare of the citizens of Illinois, to provide a system of control over the distribution and use of controlled substances which will more effectively: (1) limit access of such substances only to those persons who have demonstrated an appropriate sense of responsibility and have a lawful and legitimate reason to possess them; (2) deter the unlawful and destructive abuse of controlled substances; (3) penalize most heavily the illicit traffickers or profiteers of controlled substances, who propagate and perpetuate the abuse of such substances with reckless disregard for its consumptive consequences upon every element of society; (4) acknowledge the functional and consequential differences between the various types of controlled substances and provide for correspondingly different degrees of control over each of the various types; (5) unify where feasible and codify the efforts of this State to conform with the regulatory systems of the Federal government and other states to establish national coordination of efforts to control the abuse of controlled substances; and (6) provide law enforcement authorities with the necessary resources to make this system efficacious.
    It is not the intent of the General Assembly to treat the unlawful user or occasional petty distributor of controlled substances with the same severity as the large‑scale, unlawful purveyors and traffickers of controlled substances. However, it is recognized that persons who violate this Act with respect to the manufacture, delivery, possession with intent to deliver, or possession of more than one type of controlled substance listed herein may accordingly receive multiple convictions and sentences under each Section of this Act. To this end, guidelines have been provided, along with a wide latitude in sentencing discretion, to enable the sentencing court to order penalties in each case which are appropriate for the purposes of this Act.
(Source: P.A. 89‑404, eff. 8‑20‑95; 90‑593, eff. 6‑19‑98.)

    (720 ILCS 570/101) (from Ch. 56 1/2, par. 1101)
    Sec. 101.
    This Act shall be known as and may be cited as the "Illinois Controlled Substances Act."
(Source: P. A. 77‑757.)

    (720 ILCS 570/102)(from Ch. 56 1/2, par. 1102)
    Sec. 102. Definitions. As used in this Act, unless the context otherwise requires:
    (a) "Addict" means any person who habitually uses any drug, chemical, substance or dangerous drug other than alcohol so as to endanger the public morals, health, safety or welfare or who is so far addicted to the use of a dangerous drug or controlled substance other than alcohol as to have lost the power of self control with reference to his addiction.
    (b) "Administer" means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a patient, research subject, or animal (as defined by the Humane Euthanasia in Animal Shelters Act) by:
        (1) a practitioner (or, in his presence, by his
     authorized agent),
        (2) the patient or research subject at the lawful
     direction of the practitioner, or
        (3) a euthanasia technician as defined by the Humane
     Euthanasia in Animal Shelters Act.
    (c) "Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. It does not include a common or contract carrier, public warehouseman or employee of the carrier or warehouseman.
    (c‑1) "Anabolic Steroids" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:
            (i) boldenone,
            (ii) chlorotestosterone,
            (iii) chostebol,
            (iv) dehydrochlormethyltestosterone,
            (v) dihydrotestosterone,
            (vi) drostanolone,
            (vii) ethylestrenol,
            (viii) fluoxymesterone,
            (ix) formebulone,
            (x) mesterolone,
            (xi) methandienone,
            (xii) methandranone,
            (xiii) methandriol,
            (xiv) methandrostenolone,
            (xv) methenolone,
            (xvi) methyltestosterone,
            (xvii) mibolerone,
            (xviii) nandrolone,
            (xix) norethandrolone,
            (xx) oxandrolone,
            (xxi) oxymesterone,
            (xxii) oxymetholone,
            (xxiii) stanolone,
            (xxiv) stanozolol,
            (xxv) testolactone,
            (xxvi) testosterone,
            (xxvii) trenbolone, and
            (xxviii) any salt, ester, or isomer of a drug or
         substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.
    Any person who is otherwise lawfully in possession of an anabolic steroid, or who otherwise lawfully manufactures, distributes, dispenses, delivers, or possesses with intent to deliver an anabolic steroid, which anabolic steroid is expressly intended for and lawfully allowed to be administered through implants to livestock or other nonhuman species, and which is approved by the Secretary of Health and Human Services for such administration, and which the person intends to administer or have administered through such implants, shall not be considered to be in unauthorized possession or to unlawfully manufacture, distribute, dispense, deliver, or possess with intent to deliver such anabolic steroid for purposes of this Act.
    (d) "Administration" means the Drug Enforcement Administration, United States Department of Justice, or its successor agency.
    (e) "Control" means to add a drug or other substance, or immediate precursor, to a Schedule under Article II of this Act whether by transfer from another Schedule or otherwise.
    (f) "Controlled Substance" means a drug, substance, or immediate precursor in the Schedules of Article II of this Act.
    (g) "Counterfeit substance" means a controlled substance, which, or the container or labeling of which, without authorization bears the trademark, trade name, or other identifying mark, imprint, number or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person who in fact manufactured, distributed, or dispensed the substance.
    (h) "Deliver" or "delivery" means the actual, constructive or attempted transfer of possession of a controlled substance, with or without consideration, whether or not there is an agency relationship.
    (i) "Department" means the Illinois Department of Human Services (as successor to the Department of Alcoholism and Substance Abuse) or its successor agency.
    (j) "Department of State Police" means the Department of State Police of the State of Illinois or its successor agency.
    (k) "Department of Corrections" means the Department of Corrections of the State of Illinois or its successor agency.
    (l) "Department of Professional Regulation" means the Department of Professional Regulation of the State of Illinois or its successor agency.
    (m) "Depressant" or "stimulant substance" means:
        (1) a drug which contains any quantity of (i)
     barbituric acid or any of the salts of barbituric acid which has been designated as habit forming under section 502 (d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352 (d)); or
        (2) a drug which contains any quantity of (i)
     amphetamine or methamphetamine and any of their optical isomers; (ii) any salt of amphetamine or methamphetamine or any salt of an optical isomer of amphetamine; or (iii) any substance which the Department, after investigation, has found to be, and by rule designated as, habit forming because of its depressant or stimulant effect on the central nervous system; or
        (3) lysergic acid diethylamide; or
        (4) any drug which contains any quantity of a
     substance which the Department, after investigation, has found to have, and by rule designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect.
    (n) (Blank).
    (o) "Director" means the Director of the Department of State Police or the Department of Professional Regulation or his designated agents.
    (p) "Dispense" means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a prescriber, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery.
    (q) "Dispenser" means a practitioner who dispenses.
    (r) "Distribute" means to deliver, other than by administering or dispensing, a controlled substance.
    (s) "Distributor" means a person who distributes.
    (t) "Drug" means (1) substances recognized as drugs in the official United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; (2) substances intended for use in diagnosis, cure, mitigation, treatment, or prevention of disease in man or animals; (3) substances (other than food) intended to affect the structure of any function of the body of man or animals and (4) substances intended for use as a component of any article specified in clause (1), (2), or (3) of this subsection. It does not include devices or their components, parts, or accessories.
    (t‑5) "Euthanasia agency" means an entity certified by the Department of Professional Regulation for the purpose of animal euthanasia that holds an animal control facility license or animal shelter license under the Animal Welfare Act. A euthanasia agency is authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.
    (t‑10) "Euthanasia drugs" means Schedule II or Schedule III substances (nonnarcotic controlled substances) that are used by a euthanasia agency for the purpose of animal euthanasia.
    (u) "Good faith" means the prescribing or dispensing of a controlled substance by a practitioner in the regular course of professional treatment to or for any person who is under his treatment for a pathology or condition other than that individual's physical or psychological dependence upon or addiction to a controlled substance, except as provided herein: and application of the term to a pharmacist shall mean the dispensing of a controlled substance pursuant to the prescriber's order which in the professional judgment of the pharmacist is lawful. The pharmacist shall be guided by accepted professional standards including, but not limited to the following, in making the judgment:
        (1) lack of consistency of doctor‑patient
     relationship,
        (2) frequency of prescriptions for same drug by one
     prescriber for large numbers of patients,
        (3) quantities beyond those normally prescribed,
        (4) unusual dosages,
        (5) unusual geographic distances between patient,
     pharmacist and prescriber,
        (6) consistent prescribing of habit‑forming drugs.
    (u‑1) "Home infusion services" means services provided by a pharmacy in compounding solutions for direct administration to a patient in a private residence, long‑term care facility, or hospice setting by means of parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion.
    (v) "Immediate precursor" means a substance:
        (1) which the Department has found to be and by rule
     designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;
        (2) which is an immediate chemical intermediary used
     or likely to be used in the manufacture of such controlled substance; and
        (3) the control of which is necessary to prevent,
     curtail or limit the manufacture of such controlled substance.
    (w) "Instructional activities" means the acts of teaching, educating or instructing by practitioners using controlled substances within educational facilities approved by the State Board of Education or its successor agency.
    (x) "Local authorities" means a duly organized State, County or Municipal peace unit or police force.
    (y) "Look‑alike substance" means a substance, other than a controlled substance which (1) by overall dosage unit appearance, including shape, color, size, markings or lack thereof, taste, consistency, or any other identifying physical characteristic of the substance, would lead a reasonable person to believe that the substance is a controlled substance, or (2) is expressly or impliedly represented to be a controlled substance or is distributed under circumstances which would lead a reasonable person to believe that the substance is a controlled substance. For the purpose of determining whether the representations made or the circumstances of the distribution would lead a reasonable person to believe the substance to be a controlled substance under this clause (2) of subsection (y), the court or other authority may consider the following factors in addition to any other factor that may be relevant:
        (a) statements made by the owner or person in control
     of the substance concerning its nature, use or effect;
        (b) statements made to the buyer or recipient that
     the substance may be resold for profit;
        (c) whether the substance is packaged in a manner
     normally used for the illegal distribution of controlled substances;
        (d) whether the distribution or attempted
     distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.
    Clause (1) of this subsection (y) shall not apply to a noncontrolled substance in its finished dosage form that was initially introduced into commerce prior to the initial introduction into commerce of a controlled substance in its finished dosage form which it may substantially resemble.
    Nothing in this subsection (y) prohibits the dispensing or distributing of noncontrolled substances by persons authorized to dispense and distribute controlled substances under this Act, provided that such action would be deemed to be carried out in good faith under subsection (u) if the substances involved were controlled substances.
    Nothing in this subsection (y) or in this Act prohibits the manufacture, preparation, propagation, compounding, processing, packaging, advertising or distribution of a drug or drugs by any person registered pursuant to Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
    (y‑1) "Mail‑order pharmacy" means a pharmacy that is located in a state of the United States, other than Illinois, that delivers, dispenses or distributes, through the United States Postal Service or other common carrier, to Illinois residents, any substance which requires a prescription.
    (z) "Manufacture" means the production, preparation, propagation, compounding, conversion or processing of a controlled substance other than methamphetamine, either directly or indirectly, by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling of its container, except that this term does not include:
        (1) by an ultimate user, the preparation or
     compounding of a controlled substance for his own use; or
        (2) by a practitioner, or his authorized agent under
     his supervision, the preparation, compounding, packaging, or labeling of a controlled substance:
            (a) as an incident to his administering or
         dispensing of a controlled substance in the course of his professional practice; or
            (b) as an incident to lawful research, teaching
         or chemical analysis and not for sale.
    (z‑1) (Blank).
    (aa) "Narcotic drug" means any of the following, whether produced directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:
        (1) opium and opiate, and any salt, compound,
     derivative, or preparation of opium or opiate;
        (2) any salt, compound, isomer, derivative, or
     preparation thereof which is chemically equivalent or identical with any of the substances referred to in clause (1), but not including the isoquinoline alkaloids of opium;
        (3) opium poppy and poppy straw;
        (4) coca leaves and any salts, compound, isomer, salt
     of an isomer, derivative, or preparation of coca leaves including cocaine or ecgonine, and any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine (for the purpose of this paragraph, the term "isomer" includes optical, positional and geometric isomers).
    (bb) "Nurse" means a registered nurse licensed under the Nurse Practice Act.
    (cc) (Blank).
    (dd) "Opiate" means any substance having an addiction forming or addiction sustaining liability similar to morphine or being capable of conversion into a drug having addiction forming or addiction sustaining liability.
    (ee) "Opium poppy" means the plant of the species Papaver somniferum L., except its seeds.
    (ff) "Parole and Pardon Board" means the Parole and Pardon Board of the State of Illinois or its successor agency.
    (gg) "Person" means any individual, corporation, mail‑order pharmacy, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other entity.
    (hh) "Pharmacist" means any person who holds a license or certificate of registration as a registered pharmacist, a local registered pharmacist or a registered assistant pharmacist under the Pharmacy Practice Act.
    (ii) "Pharmacy" means any store, ship or other place in which pharmacy is authorized to be practiced under the Pharmacy Practice Act.
    (jj) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.
    (kk) "Practitioner" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist, veterinarian, scientific investigator, pharmacist, physician assistant, advanced practice nurse, licensed practical nurse, registered nurse, hospital, laboratory, or pharmacy, or other person licensed, registered, or otherwise lawfully permitted by the United States or this State to distribute, dispense, conduct research with respect to, administer or use in teaching or chemical analysis, a controlled substance in the course of professional practice or research.
    (ll) "Pre‑printed prescription" means a written prescription upon which the designated drug has been indicated prior to the time of issuance.
    (mm) "Prescriber" means a physician licensed to practice medicine in all its branches, dentist, optometrist, podiatrist or veterinarian who issues a prescription, a physician assistant who issues a prescription for a controlled substance in accordance with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5 of the Physician Assistant Practice Act of 1987, or an advanced practice nurse with prescriptive authority delegated under Section 65‑40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation, and a written collaborative agreement under Section 65‑35 of the Nurse Practice Act.
    (nn) "Prescription" means a lawful written, facsimile, or verbal order of a physician licensed to practice medicine in all its branches, dentist, podiatrist or veterinarian for any controlled substance, of an optometrist for a Schedule III, IV, or V controlled substance in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a physician assistant for a controlled substance in accordance with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5 of the Physician Assistant Practice Act of 1987, or of an advanced practice nurse with prescriptive authority delegated under Section 65‑40 of the Nurse Practice Act who issues a prescription for a controlled substance in accordance with Section 303.05, a written delegation, and a written collaborative agreement under Section 65‑35 of the Nurse Practice Act.
    (oo) "Production" or "produce" means manufacture, planting, cultivating, growing, or harvesting of a controlled substance other than methamphetamine.
    (pp) "Registrant" means every person who is required to register under Section 302 of this Act.
    (qq) "Registry number" means the number assigned to each person authorized to handle controlled substances under the laws of the United States and of this State.
    (rr) "State" includes the State of Illinois and any state, district, commonwealth, territory, insular possession thereof, and any area subject to the legal authority of the United States of America.
    (ss) "Ultimate user" means a person who lawfully possesses a controlled substance for his own use or for the use of a member of his household or for administering to an animal owned by him or by a member of his household.
(Source: P.A. 95‑242, eff. 1‑1‑08; 95‑639, eff. 10‑5‑07; 95‑689, eff. 10‑29‑07; 95‑876, eff. 8‑21‑08; 96‑189, eff. 8‑10‑09; 96‑268, eff. 8‑11‑09.)

    (720 ILCS 570/103)(from Ch. 56 1/2, par. 1103)
    Sec. 103. Scope of Act. Nothing in this Act limits the lawful authority granted by the Medical Practice Act of 1987, the Nurse Practice Act, the Illinois Optometric Practice Act of 1987, or the Pharmacy Practice Act.
(Source: P.A. 95‑242, eff. 1‑1‑08; 95‑639, eff. 10‑5‑07; 95‑689, eff. 10‑29‑07; 95‑876, eff. 8‑21‑08.)